Clinical sequencing to reach $3.6B?
The recent Macquarie report on clinical sequencing named our diagnostic decision support product, GQ-Dx, the technology leader in informatics and interpretation of clinical sequencing. In that report, they described a scenario where in as little as three years the clinical sequencing market could reach $3.6B. Believe it? GQ-Dx is our response to an overflowing demand by ...